+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Metabolic-associated fatty liver disease, An Issue of Endocrinology and Metabolism Clinics of North America. The Clinics: Internal Medicine Volume 52-3

  • Book

  • July 2023
  • Region: North America
  • Elsevier Health Science
  • ID: 5779220
In this issue of Endocrinology and Metabolism Clinics of North America, guest editors Drs. Sherouk Fouda and Joseph M. Pappachan bring their considerable expertise to the topic of Metabolic Associated Fatty Liver Disease. Top experts address the various ways metabolic associated fatty liver disease is related to other conditions such as diabetes, sarcopenia, PCOS, and more, as well as the management of MAFLD and cardiovascular implications.
  • Contains 12 practice-oriented topics including obstructive sleep apnea and MAFLD; the interlink between MAFLD and polycystic ovary syndrome; pregnancy and MAFLD; MAFLD and gut microbiota; and more.

  • Provides in-depth clinical reviews of metabolic associated fatty liver disease, offering actionable insights for clinical practice.

  • Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

Pathobiology of Metabolic-Associated Fatty Liver Disease
Metabolic-Associated Fatty Liver Disease in Childhood and Adolescence
Lean Metabolic-Associated Fatty Liver Disease
Lipid Disorders and Metabolic-Associated Fatty Liver Disease
Cardiovascular Implications of Metabolic Dysfunction-Associated Fatty Liver Disease
Metabolic-Associated Fatty Liver Disease and Diabetes: A Double Whammy
Metabolic-Associated Fatty Liver Disease and the Gut Microbiota
Metabolic-Associated Fatty Liver Disease and Sarcopenia
A Bidirectional Association Between Obstructive Sleep Apnea and Metabolic[1]Associated Fatty Liver Disease
Pregnancy and Metabolic-Associated Fatty Liver Disease
The Interlink Between Metabolic-Associated Fatty Liver Disease and Polycystic Ovary Syndrome
Management of Metabolic-Associated Fatty Liver Disease

Authors

Joseph M. Pappachan Department of Endocrinology & Metabolism, Lancashire Teaching Hospitals NHS Trust and Faculty of Science, Manchester Metropolitan University, UK.

Professor Pappachan M Joseph is a senior consultant Endocrinologist in the UK and honorary professor at the Manchester Metropolitan University. He is an associate editor to Frontiers in Clinical Diabetes & Healthcare, the World Journal of Diabetes, and TouchREVIEWS in Endocrinology. He is also in the editorial board member of the American Endocrine Society Journal - JCEM Case Reports, has fully edited multiple journal issues in the past, and is the lead editor to the Elsevier Textbook "Endocrine Hypertension: From Basic Science to Clinical Practice�. He has 135 scientific publications in his credit in peer reviewed journals and has several multinational research collaborations. His academic h-index is 35 with more than 4200 citations of his works to date. His research special interests include obesity, metabolic disorders including MAFLD, neuroendocrinology & parathyroid disorders.

Sherouk Fouda School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia.